Ligand Pharmaceuticals competitive analysis

Explore patent oppositions filed by Ligand Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 8, 2026
Patent NumberTitleApplicantOpposition Date
CyclodextrinCURADEV PHARMA PVTJan 18, 2019
A Method Of Producing An Antibody Comprising A Human Variable Region And A Rodent Constant Region.REGENERON PHARMACEUTICALSOct 31, 2018

Explore Ligand Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 8, 2026
Patent NumberPublication DateTitleTotal Oppositions
Feb 26, 2020A Diphenylsulfonamide Endothelin And Angiotensin Ii Receptor Antagonists To Treatglomerulosclerosis1

Latest PTAB cases involving Ligand Pharmaceuticals

Discover the latest PTAB cases involving Ligand Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ligand Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 8, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
LIGAND PHARMACEUTICALS INCORPORATED2 - - -
CURADEV PHARMA PVT - 1 - -
REGENERON PHARMACEUTICALS55142932